Journal of Endocrinological Investigation

, Volume 29, Issue 2, pp 147–153 | Cite as

Expression of potassium channel isoforms mRNA in normal human adrenals and aldosterone-secreting adenomas

  • R. Sarzani
  • F. Pietrucci
  • M. Francioni
  • F. Salvi
  • C. Letizia
  • E. D’Erasmo
  • P. Dessì Fulgheri
  • A. Rappelli
Original Articles

Abstract

Increased aldosterone secretion has been found in a mouse lacking the KCNE1 gene which codes for a regulatory protein of the KCNQ1 gene product, forming the channel for the outward rectifying delayed K+ current. Abnormalities in proteins regulating the K+ fluxes across membranes may be responsible for aldosterone-secreting adenomas (aldosteronomas) also because K+ channels are involved in cell growth. Normal and adenomatous adrenal samples and NCI-H295 cell line were used to: a) evaluate KCNE1 and KCNQ1 gene expression, b) sequence the full length cD-NAs of KCNE1 and both KCNQ1 isoforms. These differently spliced KCNE1 and KCNQ1 mRNAs were expressed in adrenal tissue. In contrast, KC-NQ1 isoform 2 mRNA was not expressed in kidney control tissues and NCI-H295 cell line. NCI-H295 cell line also had a significantly lower expression of KCNQ1 isoform 1 mRNA than normal adrenals and aldosteronomas. We did not find any somatic mutations in the coding sequences of both genes. This different expression pattern of KCNQ1 isoforms in NCI-H295 cell line with the lack of the mRNA for the dominant-negative KCNQ1 isoform 2 supports the involvement of voltage-gated K+ channel in cell proliferation.

En]Keywords

Aldosterone secreting adenomas KCNQ1 KCNE1 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Davies E, Bonnardeaux A, Plouin PF, Corvol P, Clauser E. Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J Clin Endocrinol Metab 1995, 82: 611–5.Google Scholar
  2. 2.
    Romey G, Attali B, Chouabe C, et al. Molecular mechanism and functional significance of the MinK control of the Kv-LQT1 channel activity. J Biol Chem 1997, 272: 1671 3–6.Google Scholar
  3. 3.
    Sanguinetti MC. Maximal function of minimal K+ channels subunits. Trends Pharmacol Sci 2000, 21: 199–201.PubMedCrossRefGoogle Scholar
  4. 4.
    Sarzani R, Opocher G, Dessl Fulgheri P, et al. Expression of type 1 angiotensin II receptors in human aldosteronomas. Endoc Res 1995, 21: 189–95.CrossRefGoogle Scholar
  5. 5.
    Mazzocchi G, Malendowicz LK, Markowska A, Albertin G, Nussdorfer G. Role of adrenal renin — angiotensin system in the control of aldosterone secretion in sodium restricted rats. American Journal of Physiology. Am J Physiol Endocrinol Metab 2000, 278: E1027–30.Google Scholar
  6. 6.
    Sarzani R, Opocher G, Paci MV, et al. Natriuretic peptides receptors in human aldosterone-secreting adenomas. J Endocrinol Invest 1999, 22: 514–8.PubMedGoogle Scholar
  7. 7.
    Sarzani R, Salvi F, Pietrucci F, et al. Absence of somatic mutations in natriuretic peptide receptor type-A gene in human aldosterone-secreting adenomas. J Mol Endocrinol 2003, 31: 317–26.PubMedCrossRefGoogle Scholar
  8. 8.
    Parma J, Duprez L, Van Sande J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649–51.Google Scholar
  9. 9.
    Parma J, Duprez L, Van Sande J, et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsα genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 1997, 82: 2695–701.PubMedGoogle Scholar
  10. 10.
    Ballare E, Mantovani S, Lania A, et al. Activating mutations of the Gsα gene are associated with low levels of Gsα protein in growth hormone secreting tumors. J Clin Endocrinol Metab 1997, 80: 4184–8.Google Scholar
  11. 11.
    Casimiro MC, Knollmann BC, Ebert SN, et al. Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen syndrome. Proc Natl Acad Sci U S A 1998: 2526–31.Google Scholar
  12. 12.
    Sanguinetti MC, Curran ME, Zou A, et al. Coassembly of K(v)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996, 84: 80–3.CrossRefGoogle Scholar
  13. 13.
    Suessbrich H, Busch AE. The Isk channel: coassembly onf Isk (minK) and KVLQT1 proteins. Rev Physiol Biochem Pharmacol 1999, 137: 191–26.PubMedGoogle Scholar
  14. 14.
    Arrighi I, Bloch-Faure M, Grahammer F, et al. Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome. Proc Natl Acad Sci U S A 2001, 98: 8792–7.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT. Genomic structure of three Long QT Syndromes genes: KVLQT1, HERG and KCNE1. Genomics 1998, 5186–97.Google Scholar
  16. 16.
    Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G 1996 K(v)LQT1 and IsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996, 384: 78–80.PubMedCrossRefGoogle Scholar
  17. 17.
    Murray A, Donger C, Fenske C, et al. Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. Circulation 1999, 100: 1077–84.PubMedCrossRefGoogle Scholar
  18. 18.
    Demolombe S, Baró I, Péréon Y, et al. A dominant negative isoform of the long QT syndrome 1 gene product. J Biol Chem 1998, 273: 6837–43.PubMedCrossRefGoogle Scholar
  19. 19.
    Jiang M, Tseng-Crank J, Tseng GN. Suppression of slow delayed rectifier current by a truncated isoform of KVLQT1 cloned from normal human heart. J Biol Chem 1997, 272: 24109–12.PubMedCrossRefGoogle Scholar
  20. 20.
    Yang WP, Levesque PC, Little WA, Conder ML, Shalaby FY, Blanar MA. KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U S A 1997, 94: 4017–21.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Sarzani R, Fallo F, Dessl Fulgheri P, et al. Local renin — angiotensin system in human adrenals and aldosteronomas. Hypertension 1992, 19: 702–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162: 156–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Sarzani R, Pietrucci F, Francioni M, et al. Human aldosterone secreting adenoma specifically express dominant negative KC-NQ1 isoform 2 mRNA. Hypertension 2003, p. 638 (abstract).Google Scholar
  24. 24.
    Zhou Q, Kwan HY, Chan HC, Jiang JL, Tam SC, Yao X. Blockage of voltage-gated K+ channels inhibits adhesion ad proliferation of hepatocarcinoma cells. Int J Mol Med 2003, 11: 261–6.PubMedGoogle Scholar
  25. 25.
    Abdul M, Santo A, Hoosein N. Activity of potassium channel-blockers in breast cancer. Anticancer Res 2003, 23: 3347–51.PubMedGoogle Scholar
  26. 26.
    Crociani O, Guasti L, Balzi M, et al. Cell cycle-dependent expression of HERG1 and HERG1 B isoforms in tumor cells. J Biol Chem 2003, 278: 2947–55.PubMedCrossRefGoogle Scholar
  27. 27.
    Abdul M, Hoosein N. Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett 2002, 186: 99–105.PubMedCrossRefGoogle Scholar
  28. 28.
    Abdul M, Hoosein N. Voltage-gated potassium ion channels in colon cancer. Oncol Rep 2002, 9: 961–4.PubMedGoogle Scholar
  29. 29.
    Sakai H, Shimizu T, Hori K, Ikari A, Asano S, Takeguchi N. Molecular and pharmacological properties of inwardly rectifying K+ channels of human lung cancer cells. Eur J Pharmacol 2002, 435: 125–33.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2006

Authors and Affiliations

  • R. Sarzani
    • 1
  • F. Pietrucci
    • 1
  • M. Francioni
    • 1
  • F. Salvi
    • 1
  • C. Letizia
    • 2
  • E. D’Erasmo
    • 2
  • P. Dessì Fulgheri
    • 1
  • A. Rappelli
    • 1
  1. 1.Department of Internal MedicinePolytechnical University of Marche, Ospedali Riuniti “Umberto I — Lancisi — Salesi”AnconaItaly
  2. 2.Department of Clinical SciencesUniversity of Rome “La Sapienza”RomeItaly

Personalised recommendations